Try it
General Surgery · Breast and endocrine surgery: aromatase inhibitors in premenopausal women
Sample itemWhy are aromatase inhibitors alone ineffective as adjuvant endocrine therapy in a woman with intact ovarian function?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Loss of oestrogen feedback raises gonadotrophins and ovarian oestrogen output
In premenopausal women, aromatase inhibitors reduce oestrogen, which removes negative feedback on the pituitary. Rising FSH and LH then stimulate the ovaries to make more oestrogen, overcoming the block. They are used only after menopause or with ovarian suppression.
Option by option
A. They block progesterone receptors only
Aromatase inhibitors block oestrogen synthesis, not progesterone receptors.
B. Loss of oestrogen feedback raises gonadotrophins and ovarian oestrogen output (correct)
Correct. The feedback loop restores ovarian oestrogen production.
C. Ovarian tissue does not express aromatase
Ovarian granulosa cells do express aromatase, which is why suppression is needed.
D. They are inactivated by hepatic enzymes in young women
Hepatic inactivation does not explain the poor response.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More General Surgery questions
- HerniaA groin hernia that passes medial to the inferior epigastric vessels through Hesselbach'…
- BurnsA 70 kg adult has burns over 40% of the body surface. By the Parkland formula, what tota…
- HerniaA hernia that enters the inguinal canal through the deep ring, lateral to the inferior e…
- Intestinal obstructionWhat is the commonest cause of small bowel obstruction in adults?